MEDS: Company acquired by Intrexon Corporation (XON). Shareholders receive $0.27 in cash and approximately 0.03920 shares of XON per each one share of MEDS, subject to adjustment pursuant to the terms of the merger agreement. Deletion Time: 8:35:00.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.